CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-12 | MORSE DANIEL E. Former Director | Sale | −7,047 | $1.31 | $9K | 20,741 |
| 2018-03-29 | MORSE DANIEL E. Director | Sale | −4,366 | $0.81 | $4K | 0 |
| 2018-03-12 | MORSE DANIEL E. Director | Sale | −3,500 | $0.80 | $3K | 4,366 |
| 2018-03-12 | MORSE DANIEL E. Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2018-03-09 | MORSE DANIEL E. Director | Sale | −7,000 | $0.81 | $6K | 7,866 |
| 2018-02-28 | MORSE DANIEL E. Director | Sale | −7,000 | $0.79 | $6K | 14,866 |
| 2018-02-26 | MORSE DANIEL E. Director | Sale | −7,000 | $0.79 | $6K | 21,866 |
| 2018-02-22 | MORSE DANIEL E. Director | Sale | −7,800 | $0.78 | $6K | 28,866 |
| 2017-06-26 | MORSE DANIEL E. Director | Grant or award | +134,680 | 231,189 | ||
| 2017-03-23 | MORSE DANIEL E. Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | MORSE DANIEL E. Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2015-06-10 | MORSE DANIEL E. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 1 of 1 · 12 trades